Todd Mcdevitt

Company: Genentech

Job title: Vice President, Head of Cell Therapy

Seminars:

Roundtable Discussion: Unlocking the Full Potential of Treg Cells: Beyond Therapeutic Frontiers 10:30 am

As Treg therapies continue to demonstrate their efficacy in autoimmune and inflammatory conditions, this session explores the broader landscape of opportunities that Treg cells can provide for diverse therapeutic applications Delve into the untapped potential of Tregs and discuss how their success can be leveraged to shape the future of immunotherapy Explore avenues for expanding…Read more

day: Day Two AM Cell-Based Approaches